Cointime

CanSinoBIO

company

About

Tianjin CanSino Biotechnology Inc. is a vaccine manufacturing facility.

  • 101 - 250

Highlights

Total Funding Amount
$105M
Funding Rounds
3
Investors
1

Details

Last Funding Type
Series C
Last Funding Money Raised
$30M
Industries
Biopharma,Biotechnology,Health Care,Medical,Medical Device
Founded date
Jan 1, 2009
Number Of Employee
101 - 250
Operating Status
Active

Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$105M
CanSinoBIO has raised a total of $105M in funding over 2 rounds. Their latest funding was raised on Apr 19, 2017 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 19, 2017 Series E $65M 1 — — Detail
Nov 3, 2015 Series C $30M 1 — — Detail
Sep 16, 2013 Series Unknown $10M 1 Lilly Asia Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
CanSinoBIO is funded by 1 investors. Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Lilly Asia Ventures — Series E
Cointime
เนื้อหา
บริษัท